The BMI Clinic

What The BMI Clinic does

The BMI Clinic is an Australian private healthcare clinic founded in 2005 (originally as Gastric Balloon Australia by Prof. George Marinos) that specialises in medical, endoscopic, and surgical weight loss treatments for adults with obesity and weight-related comorbidities. Operating from three locations — Sydney Double Bay, Sydney Liverpool, and Melbourne (opened 2023) — and supported by telehealth consultations for interstate patients, the clinic is led medically by Dr. Adrian Sartoretto (Medical Director, who performed Australia's first Endoscopic Sleeve Gastroplasty in 2016) and a multidisciplinary team of bariatric specialists, dietitians, behavioural coaches, and exercise specialists.

The clinic's core technology spans a full procedure menu: intragastric balloons (Allurion swallowable balloon, Orbera fixed balloon, Spatz3 adjustable balloon — Australia's first and only adjustable 12-month balloon since 2014, with 6,000+ procedures performed), Endoscopic Sleeve Gastroplasty (ESG, non-surgical, performed entirely via the mouth and reducing stomach volume by ~75%), Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y and Mini Gastric Bypass, Adjustable Gastric Banding, and the TORe endoscopic revision procedure. These are paired with tiered lifestyle support programs (Silver, Gold, Platinum) of dietitian, exercise, and behavioural coaching consultations, and supported by custom-built proprietary patient monitoring software, Wi-Fi-enabled Allurion smart scales, DEXA body-composition scanning, and exclusive post-procedure IV hydration via a partnership with The Infusion Clinic.

The BMI Clinic generates revenue from per-procedure fees bundled with lifestyle program tiers, plus standalone lifestyle programs, weight loss medications, and supplementary clinical-trial revenue (e.g., the sponsor-funded PANORAMIC Study for Type 2 Diabetes). Pricing is not publicly disclosed; only LSG and Gastric Bypass qualify for private health insurance rebates, while balloons and ESG are self-funded with patient financing facilitated through Zip Money, TLC, MediPay, and Access My Super (early superannuation release). The go-to-market is sales-led, anchored by a free information call as the low-friction conversion point, complemented by content marketing, social media, patient testimonials, and clinical-trial recruitment.

Name

The BMI Clinic

Legal name

The BMI Clinic

Website

https://bmiclinic.com.au

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

The BMI Clinic is an Australian private healthcare clinic that delivers surgical, endoscopic, and lifestyle-program-based weight loss treatments to adults with obesity and weight-related comorbidities from three Australian locations. It pioneered Spatz3 and Endoscopic Sleeve Gastroplasty in Australia and pairs procedures with tiered multidisciplinary support programs.

Ownership category

akta.pro rank

Product category

Bariatric & Weight Loss Clinic Services

NAICS

Freestanding Ambulatory Surgical and Emergency Centers (621493), Diet and Weight Reducing Centers (812191)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

akta.pro secondary industries

General Gastroenterology (HLAKAEAA), General Nutrition Coaching (HSADAFAA)

Keywords

• Bariatric weight loss
• Gastric balloon procedures
• Endoscopic sleeve gastroplasty
• Bariatric surgery services
• Obesity treatment clinic

Headquarters

HQ city

Sydney

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Weight Loss Procedures and Programs: The BMI Clinic generates revenue from a suite of weight loss procedures including intragastric balloons (Allurion, Orbera, Spatz3), Endoscopic Sleeve Gastroplasty (ESG), Laparoscopic Sleeve Gastrectomy (LSG), Gastric Bypass (Roux-en-Y and Mini), and Adjustable Gastric Banding. Each procedure is paired with a tiered lifestyle support program (Silver, Gold, or Platinum) that includes consultations with dietitians, behavioural coaches, exercise specialists, and bariatric physicians. The clinic also offers standalone Lifestyle Weight Loss Programs and weight loss medications.
2. Lifestyle and Support Programs: All procedures are accompanied by a comprehensive support program bundled into tiers (Silver, Gold, Platinum). These programs provide ongoing dietitian, behavioural, exercise specialist, and bariatric physician consultations over the program duration. The more consultations a patient has, the greater the weight loss outcome (data shows an extra 0.4kg per additional consultation), making the program a recurring engagement model throughout the patient's weight loss journey.
3. Payment Plan Financing: The clinic offers multiple third-party financing options to patients: Zip Money (12 months interest-free for amounts under $15,000), TLC Total Lifestyle Credit (interest rates from 6.45%, loans from $2,001 to $50,000), and MediPay (11.99%-21.99% per annum). These financing arrangements facilitate higher procedure uptake by distributing costs over time.
4. Early Superannuation Release Assistance: The clinic partners with Access My Super to assist patients in obtaining early release of superannuation to fund weight loss treatment, subject to ATO criteria (weight-related pain requirements). A $499 fee is payable to Access My Super for processing this service.
5. Clinical Trial Conduct: The clinic conducts clinical trials (e.g., PANORAMIC Study for Type 2 Diabetes, HybridAPC in GMA Clinical Trial) sponsored by external organisations. Treatment costs are covered or subsidised by trial sponsors, and participants receive stipends for travel and time. This represents a research services revenue stream funded by external sponsors such as Ascend Clinical Research Organisation Pty Ltd.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels8 records

Core offering

The BMI Clinic delivers bariatric and endoscopic weight loss procedures — including gastric balloons (Spatz3, Allurion, Orbera), Endoscopic Sleeve Gastroplasty (ESG), Laparoscopic Sleeve Gastrectomy (LSG), Adjustable Gastric Banding, and Roux-en-Y and Mini Gastric Bypass — bundled with tiered lifestyle support programs (Silver, Gold, Platinum) involving dietitians, behavioural coaches, exercise specialists, and bariatric physicians. It also runs lifestyle-only weight management programs and conducts sponsored clinical trials in metabolic health.

Product overview

The BMI Clinic is Australia's leading weight loss clinic offering a comprehensive portfolio of both non-surgical and surgical weight loss procedures. The non-surgical offerings include gastric balloons (Spatz3 Adjustable, Allurion, and Orbera) and Endoscopic Sleeve Gastroplasty (ESG), while surgical options include Adjustable Gastric Banding, Laparoscopic Sleeve Gastrectomy (LSG), Roux-en-Y Gastric Bypass, and Mini Gastric Bypass. All procedures are accompanied by a holistic Lifestyle Program providing multidisciplinary support including dietitians, exercise specialists, and behavioural coaches. The clinic also conducts clinical trials including the PANORAMIC Study for Type 2 Diabetes and HybridAPC in GMA study. Treatment tiers include Silver, Gold, and Platinum programs offering different levels of support and follow-up care.

Differentiator

Problem solved

Functional benefit

Brands

• Allurion: Swallowable gastric balloon program offered at The BMI Clinic.
• Orbera
• Spatz3
• PANORAMIC Study

Products and services

• Spatz3 Adjustable Intragastric Balloon The only 12-month gastric balloon approved for use in Australia and the only adjustable gastric balloon worldwide. It is implanted without surgery and stays for up to 12 months, with adjustable size to maximise weight loss outcomes for adults with overweight or obesity.
• Allurion Gastric Balloon A swallowable gastric balloon option that helps patients feel full sooner and longer, manage hunger, adopt healthy habits, and naturally reduce portions through a 6-month program, for adults seeking non-surgical weight loss.
• Orbera Gastric Balloon A soft, silicone balloon implanted in the stomach without surgery for up to 6 months to help reduce hunger and portion sizes, achieving an average of 12% total body weight loss for adults with overweight or obesity.
• Endoscopic Sleeve Gastroplasty (ESG) A revolutionary non-surgical procedure performed entirely through the mouth, reducing stomach size by approximately 75% through internal sutures, resulting in 20-25% total body weight loss for adults seeking non-surgical bariatric intervention.
• Laparoscopic Sleeve Gastrectomy (LSG) / Gastric Sleeve Surgery Surgical procedure that removes a large portion of the stomach along the greater curve, reducing stomach volume by approximately 85%, resulting in 20-30% total body weight loss for adults with obesity.
• Adjustable Gastric Banding Surgery A minimally invasive surgical procedure involving placement of an inflatable silicone ring around the upper part of the stomach via laparoscopic (keyhole) surgery for adults with obesity.
• Roux-en-Y Gastric Bypass A surgical procedure that divides the stomach into a small pouch about the size of a walnut and diverts food around the first part of the intestine, resulting in 25-30% total body weight loss for adults with obesity.
• Mini Gastric Bypass A surgical weight loss procedure that creates a smaller stomach pouch and reroutes the intestine, resulting in 30-35% total body weight loss for adults with obesity.
• TORe Gastric Bypass Revision Transoral Outlet Revision — an endoscopic suturing procedure performed on patients who have had a gastric bypass to revise the outlet if it has stretched over time, for adults experiencing weight regain after prior bariatric surgery.
• Lifestyle Weight Loss Program A comprehensive, best-practice weight management program backed by the latest weight loss science and an integrated team of bariatric doctors, dietitians, exercise specialists and behavioural coaches, offered both standalone and bundled with procedures in Silver, Gold, and Platinum tiers.
• PANORAMIC Study (Duodenal Mucosal Regeneration Clinical Trial) Clinical research study evaluating a new minimally invasive procedure called Duodenal Mucosal Regeneration (DMR) for adults living with Type 2 Diabetes, targeting the lining of the duodenum to help regenerate healthier tissue; treatment costs covered or subsidised by sponsor.
• HybridAPC in GMA Clinical Trial First-in-human clinical study investigating the safety and feasibility of a new potential treatment for weight loss using the Gastric Mucosal Ablation (GMA) Procedure for adults with obesity.

Quantifiable outcome

• Spatz3 patients at The BMI Clinic achieve 18.2% average total body weight loss vs 16.4% in other published studies — a 10%+ relative improvement
• +6 more outcomes

Named customers12 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core and minor.

• The Infusion CliniccoreStrategic or Co-development PartnerThe Infusion Clinic is a partner organisation providing exclusive IV hydration and medication services to The BMI Clinic's patients post-procedure. Dr. Adrian Sartoretto holds Medical Director positions with both The BMI Clinic and The Infusion Clinic, indicating a shared leadership connection. This partnership enables the clinic's fast recovery protocols, with patients receiving IV hydration and medications in the days following procedures to minimise symptoms and optimise recovery.
• The Australian Breath Analysis LaboratoryminorStrategic or Co-development PartnerThe Australian Breath Analysis Laboratory is a related entity under Dr. Adrian Sartoretto's Medical Director oversight. This laboratory may support the clinic's metabolic and clinical research activities, though specific details of the partnership are not extensively detailed in available sources.

Scale indicators10 records

Recent moves9 records

Expansion highlights7 records

Others

• Allurion Technologies: US-based company behind the swallowable Allurion gastric balloon program offered at The BMI Clinic. Supplier/ecosystem partner whose commercial trajectory directly affects The BMI Clinic's Allurion revenue line.
• Apollo Endosurgery: US-listed medical device company that manufactures the Orbera intragastric balloon and OverStitch endoscopic suturing system used in ESG. Indirect comparator as the upstream technology supplier enabling The BMI Clinic's endoscopic procedures.
• Spatz Medical: Manufacturer of the Spatz3 adjustable gastric balloon, in which The BMI Clinic is Australia's largest and most experienced provider (6,000+ procedures since 2014). Supplier/ecosystem partner whose regulatory and product roadmap underpins a major portion of the clinic's procedure volume.

Emerging players

• Juniper: Australian telehealth weight loss platform offering medically supervised GLP-1 medication programs. Targets the same obese Australian demographic via a lower-friction, non-surgical delivery model and represents the medication-first competitive threat.
• Eucalyptus (formerly Pilot): Australian digital health platform running multiple condition-specific telehealth clinics including a weight loss offering. Competes for the same Australian obesity patients via subscription telehealth and prescription medications.

Direct peers

• SmartShape Weight Loss Centre: Australian bariatric clinic offering gastric sleeve, gastric bypass, and gastric banding surgery with bundled aftercare programs. Direct competitor in the same Sydney/Melbourne patient pool and procedure mix.
• Newcastle Obesity Centre: Australian specialist obesity clinic providing surgical and endoscopic weight loss procedures including gastric balloons, sleeve gastrectomy, and gastric bypass. Comparable patient demographic and multidisciplinary service model.
• Bariatric Solutions Australia: Australian bariatric provider offering gastric sleeve, bypass, banding and intragastric balloon procedures with program-based support. Competes for the same medically-supervised weight loss patient segment in Australia.

Broad incumbents

• Healthscope (Bariatric Surgery): Major Australian private hospital operator offering bariatric surgery across multiple sites. Large incumbent with overlapping surgical offerings but without The BMI Clinic's endoscopic specialisation (ESG, intragastric balloons).
• Ramsay Health Care Australia (Bariatric Services): Large Australian private hospital network that performs bariatric surgery (sleeve gastrectomy and gastric bypass) as part of a broader multi-specialty surgical offering. Provides similar surgical procedures but as one service line within a diversified hospital portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xfacebook.com/TheBMIClinic
• YouTubeyoutube.com/channel/UCGhH9xsoXKnR-LYS8cgnWmw
• Facebookfacebook.com/TheBMIClinic
• LinkedInlinkedin.com/company/gastric-balloon-australia
• Instagraminstagram.com/thebmiclinic

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The BMI Clinic